| 000 | 01672 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512081209.0 | ||
| 264 | 0 | _c19860527 | |
| 008 | 198605s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/978-1-4615-9442-0_23 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLagarde, M | |
| 245 | 0 | 0 |
_aRole of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c1985 |
||
| 300 |
_a327-35 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _a12-Hydroxy-5,8,10,14-eicosatetraenoic Acid |
| 650 | 0 | 4 | _a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid |
| 650 | 0 | 4 | _aArachidonate Lipoxygenases |
| 650 | 0 | 4 | _aArachidonic Acid |
| 650 | 0 | 4 |
_aArachidonic Acids _xpharmacology |
| 650 | 0 | 4 |
_aBlood Platelets _xphysiology |
| 650 | 0 | 4 |
_aEicosanoic Acids _xblood |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyeicosatetraenoic Acids _xpharmacology |
| 650 | 0 | 4 |
_aLipoxygenase _xblood |
| 650 | 0 | 4 |
_aPhospholipids _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xpharmacology |
| 650 | 0 | 4 | _aProstaglandin H2 |
| 650 | 0 | 4 |
_aProstaglandins H _xpharmacology |
| 700 | 1 | _aCroset, M | |
| 700 | 1 | _aGuichardant, M | |
| 700 | 1 | _aDechavanne, M | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 192 _gp. 327-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4615-9442-0_23 _zAvailable from publisher's website |
| 999 |
_c3944609 _d3944609 |
||